BLOG: At the one-year mark of the COVID-19 pandemic, I turn again, as I did in March 2020, to writing to make sense of my world. I am tired, I am frustrated, and I am weary. But, like you, I am still here.
BLOG: In a recent study, the utilization of psychedelic medicine in group therapy was linked with reduced demoralization among long-term, gay-identified, male HIV survivors—an outcome with larger implications for overall healthcare.
BLOG: Psychedelic-assisted therapies, once consigned to the fringes of psychiatric practice, are exploding into the mainstream of psychiatry and will take center stage at a Psych Congress preconference.
BLOG: More patients are exploring the medicinal aspects of cannabis for their psychiatric conditions, and many are presenting to their providers already convinced of the benefits of their self-treatments.
BLOG: We know that isolation is one of the drivers of suicide in doctors. But listening to how doctors are affected in their heroic work on the front lines of the COVID-19 epidemic gives me hope that barriers to openly sharing one’s personal distress are lowering.
BLOG: In the middle of a crisis, it is difficult to plan ahead, but that is what we must do now, not only for those impacted by this current wave of the COVID-19 pandemic, but also to build inner resilience to care for those who may be impacted by a coming wave in the fall.